According to the latest data from the Hong Kong Stock Exchange, on October 20, Nanjing Lizhi Enterprise Management Consulting Center (Limited Partnership) reduced its holdings in LEADS BIOLABS-B (09887) by 16,500 shares at a price of HK$43.6720 per share, for a total amount of approximately HK$720,600.
Following the reduction, the latest number of shares held is approximately 29,500,300 shares, and the latest shareholding ratio is 14.92%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments